NCT05057234View on ClinicalTrials.gov

PRecision Oncology Evidence Development in Cancer Treatment - Liquid

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

June 18, 2021

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
Cancer
Interventions
DIAGNOSTIC_TEST

FoundationOne liquid CDx

FoundationOne liquid CDx testing

BEHAVIORAL

Quality of life questionnaires

Quality of life questionnaire - EQ5D

Trial Locations (1)

V5Z4E6

BC Cancer, Vancouver

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

British Columbia Cancer Agency

OTHER